AstraZeneca shows its appetite for grabbing a larger slice of China's $41 billion (£26 billion) pharmaceuticals market, announcing the country will become home to the most expensive factory it has ever built... more
Investors dumped shares in pharmaceutical giant AstraZeneca as its biggest-selling drug failed to beat US rival Pfizer's product in head-to-head tests... more
Pharmacists have been ordered to open every pack of Nurofen Plus before sale amid fears dangerous anti-psychotic drugs may have been deliberately placed in thousands of packets across London... more
AstraZeneca's blockbuster heartburn and ulcer drug Nexium has finally been approved in Japan, giving it a new lease of life just as it faces generic competition in some Western markets... more
The withdrawal symptoms of an emptying drugs cabinet hit AstraZeneca. Patent expiries mean its pre-tax profit dropped 7% to $3.3 billion in the first quarter... more
AstraZeneca says the U.S. Food and Drug Administration would decide on whether to approve its key new heart drug Brilinta by July and it remains confident about the application... more
Drugmaker AstraZeneca gets the thumbs-down from the City after a disappointing 26% dive in profits and a sales squeeze from cut-price rivals in the US... more
AstraZeneca gets a boost as the European Commission approves its schizophrenia and bipolar drug Seroquel XR as a treatment for major depressive episodes where antidepressants haven’t worked... more
AstraZeneca’s bill to pay off one of its biggest legal headaches hits £877 million as the drugs giant settles thousands of US claims over Seroquel... more
British drugmaker AstraZeneca posts a 15% rise in first-half profit and has first nod of approval for its new blood-thinning medicine from US regulators... more
Blockbuster sales of cholesterol drug Crestor and schizophrenia medicine Seroquel help AstraZeneca report an 11% surge in first-quarter revenue... more
Pharmaceuticals giant AstraZeneca today spent up to $1.2 billion (£722 million) on what it hopes will be the next worldwide anti-depressant blockbuster... more
AstraZeneca could face as many as 6000 lawsuits after a judge in America ruled that claims against its psychiatric treatment Seroquel should be put on trial separately... more
British drug giant AstraZeneca was today suffering the ill effects of medical research that criticised Seroquel, a schizophrenia medicine that is the pharma firm's second best-selling product ... more
Pharmaceuticals giant AstraZeneca received a boost when the US drug watchdog took the first steps to approve its $4.5 billion anti-psychotic medicine Seroquel for use by children... more
AstraZeneca has been told by the US Food and Drug Administration that its second biggest-selling drug should not be used as a major treatment for depression... more
Two years ago the fortunes of private-equity companies were riding high, but not any more. The credit crunch and subsequent stock market crash have made life difficult for the likes of 3i Group, which saw its shares slump to yet another new low today.... more
Drug firm AstraZeneca is due to find out today the fate of its case against generic drug maker Teva Pharmaceutical Industries in the fight to protect its blockbuster drug Seroquel... more
Morning:
9°c
